California Gov. Gavin Newsom briefed the state on its current COVID-19 status Monday, highlighting a 27% 7-day decrease in infections and a drop in hospitalizations since its peak in early January.
The state had a single-day high of more than 50,000 positive COVID-19 cases on Jan. 8, and on Feb. 8, recorded 10,209 cases. In that same time, the state had a 14% positivity rate, which has now decreased to 5%.
In the last 14 days, there has been a 34% decrease in the state’s number of COVID-19 related hospitalizations and a 25% reduction in ICU capacity.
Newsom also noted that the state’s daily vaccinations have doubled over the last two weeks, with a total of 4.65 million people being receiving doses, but also said, “Supply is our No. 1 constraint.”
“Last week we received just over 1 million vaccines doses… 594,000 of those were first doses, just 594,000 in a state of 40 million… simply not enough. Everyone recognized that from the president on down,” Newsom said. “We need to see that ramped up. We’re going to need to see more doses coming in to the state of California in order to keep these max sites operational and to keep things moving.”
On Feb. 3, Newsom had announced a federal partnership with the Biden administration, with new super sites at Cal State University, Los Angeles and the Oakland Coliseum scheduled to open on Feb. 16.
The sites would be co-operated by local workers and the Federal Emergency Management Agency (FEMA).
With one of those sites opening in Los Angeles, Mayor Eric Garcetti said that there was a promise of additional supply of vaccines and state and federal workers.
“As long as we’re not poaching each other’s supply… this is going to be added supply, added locations and added convenience,” Garcetti said in a Feb. 5 briefing.
Newsom said he is hopeful the Food and Drug Administration will approve the emergency use of Johnson & Johnson’s single-dose vaccine, which saw a 72% efficacy rate in U.S. trials. Johnson & Johnson believes it can provide the U.S. an additional 100 million doses by June of this year.
“We are working every day, working very collaboratively, encouraging the Biden administration to do everything in their power to not only accelerate the distribution of the Pfizer and Moderna vaccines… but with the appropriate level of scrutiny, that the FDA will move forward with the emergency use authorization of the J&J vaccine,” Newsom said.